The muscle logic behind the lift
The eyebrow sits at the mercy of a tug of war. One muscle lifts it and several pull it down, and the resting height of your brow is simply where that contest settles.
The lifter is the frontalis, the broad sheet across the forehead. Working against it are the corrugator supercilii, which draws the brow inward and down, the depressor supercilii, which pulls it straight down at the inner end, the procerus, which pulls down centrally between the brows, and the lateral fibres of orbicularis oculi, which pull down at the outer end.
A chemical brow lift does not strengthen the frontalis. It weakens the opposition. Place toxin precisely into the depressors and the frontalis wins the tug of war by a slightly larger margin, and the brow settles higher.
This is why the treatment is entirely anatomical rather than cosmetic in its logic, and why an injector who understands the muscle map achieves results that one following a template does not. The pattern of depressor dominance varies considerably between faces.
How much lift is realistic
One to three millimetres. That is the realistic number, and it is worth sitting with because it is far less than most patients imagine when they hear the word "lift".
Published measurements consistently land in this range, with lateral brow elevation typically exceeding medial elevation. Two millimetres does not sound like much. On a face it is enough to open the eye aperture visibly, reduce the appearance of hooding at the outer corner, and soften a habitually stern expression. It is not enough to correct genuine brow ptosis, and it will not lift skin that has descended significantly.
The patients most pleased with the result share a profile: reasonable skin quality, mild lateral heaviness rather than true descent, strong depressor activity, and an expectation calibrated to millimetres rather than centimetres.
The technique
A typical chemical brow lift involves treating three areas, with dosing adjusted to the individual's muscle pattern.
- Glabellar complex, treating corrugator and procerus. This releases the medial brow and is the same treatment used for frown lines.
- Depressor supercilii, a small dose just under the medial brow head.
- Lateral orbicularis, one to three units placed superficially above the tail of the brow. This produces most of the visible lateral lift.
Frontalis is treated conservatively or not at all in a brow lift. Treating it heavily is the classic error: it removes the lifter along with the depressors and drops the brow rather than raising it. Many patients who report that toxin "made my eyes look heavy" have experienced exactly this.
Onset is gradual, with the first change at three to five days and the full effect at two weeks. Assessment before fourteen days is premature, and any top-up should wait until then.
Why it fails when it fails
Three failure modes account for most disappointment.
The wrong diagnosis. Brow heaviness caused by excess upper eyelid skin, dermatochalasis, will not improve with toxin, because the problem is skin rather than muscle balance. Some patients in this group are surgical candidates and should be told so rather than sold a treatment that cannot work.
Frontalis over-treatment. Covered above, and the most common technical error.
The Spock brow. Excessive lateral frontalis relaxation combined with unopposed medial lift produces a sharply peaked, quizzical arch. It is correctable with one or two units in the right place, and it is avoidable with better initial placement.
A fourth, subtler failure is treating a patient whose brow position is fine but whose real concern is upper face volume loss. Toxin will not address that, and a small amount of filler in the temple or the brow fat pad often will. Practices working in regenerative and structural aesthetics, such as Mesglo London in Marylebone, tend to assess the upper face as a volumetric and tissue-quality question rather than purely a muscular one, which is the assessment this group of patients actually needs.
Alternatives when toxin is not enough
Costs for each of these are set out in our 2026 UK price guide, and the energy-device options are covered in our assessment of what the Endolift evidence supports.
| Option | Realistic lift | Duration | Downtime |
|---|---|---|---|
| Chemical brow lift | 1 to 3mm | 3 to 4 months | None |
| Brow filler or biostimulator | Structural support, not lift | 9 to 18 months | Minimal |
| Thread lift | 3 to 6mm | 9 to 18 months | 3 to 7 days |
| Energy devices, ultrasound or RF | 1 to 3mm | 12 months, cumulative | None to minimal |
| Surgical brow lift | Whatever is planned | Years | 1 to 2 weeks |
The sensible sequence for most patients is to start with toxin. It is cheap, reversible by attrition, and it reveals how much of the problem was muscular. If two millimetres transforms the face, the diagnosis was right. If it changes nothing, the problem was never muscle balance, and that is useful information before committing to anything more permanent.
Cost and maintenance
In London a chemical brow lift is usually priced either as an add-on to a standard toxin treatment, adding roughly £60 to £120, or as a standalone treatment at £180 to £320. Treating it as an add-on to glabellar treatment is generally better value, since the glabellar injections are doing part of the work regardless.
Maintenance runs at three to four times a year. Some patients find the interval lengthens over time as chronically overactive depressors weaken with repeated treatment, which is one of the few genuine long-term benefits of consistent toxin use.
